| | MANAGEMENT OF DIAABETES MELLITUS |
 | | Conversely, patients with advanced microvascular complications and/or major comorbid illness may be less likely to show survival benefit, may continue to show progression of microvascular disease, and frequently may be at increased risk for severe hypoglycemic morbidity when normoglycemic control is attempted. |
 | | Long-term outcomes (survival and occurrence of microvascular complications) of treatment of DM are related to the degree of glycemic control achieved, but not to the means used to achieve control (diet/exercise vs. oral hypoglycemic agent vs. insulin, or any known combination therapy). |
 | | Therefore, it should be recognized that maximal benefits of glycemic control in preventing the progression of microvascular disease to the endpoints of visual loss or chronic renal insufficiency accrue over a period of time longer than that of the study period of the aforementioned trial. |
| www.humanitas.com /vha/dm/expanded_g.htm (8255 words) |